Immunogenicity and Safety of Fractional Booster Dose of COVID-19 Vaccines Available for Use in Pakistan/Brazil: A Phase 4 Dose-optimizing Trial
Clinical trial NCT05343871 · COMPLETED
Trial details
- NCT number
- NCT05343871
- Sponsor
- Albert B. Sabin Vaccine Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-05
- Primary completion
- 2023-07-28
- Enrollment
- 2354
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.